chartexchange

New PHIL Research on the Future of Pharma DTP: 3 in 4 Leaders Report Direct-to-Patient a Major Strategic Priority Today, Growing 20% in “Mission Critical” Significance in 2027

Business Wire | Oct 20, 2026 10:00 AM EDT

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--A new research survey of 74 U.S. life sciences leaders finds direct-to-patient's mission-critical urgency is rising.

Read original article